- Advertisement -
Wednesday, March 3, 2021
- Advertisement -

US govt to pay J&J $1 billion for 100 million doses of COVID-19 vaccine

Johnson & Johnson will develop and deliver 100 million doses of its experimental coronavirus vaccine for the US in a deal that totals over $1 billion.

00:47:53

Queen Bey Of Hollywood – Beyoncé Knowles | Exclusive Video

Here's the Queen Bey Of Hollywood 'Beyoncé Knowles' exclusive video which you'll have never seen. Beyoncé Knowles is a multi-platinum, Grammy Award-winning recording artist who's...
00:13:04

Throwback Video: Launch Party Of Saif Ali Khan And Jackie Shroff’s Film Tum

Watch the launch party of the Hindi film 'Tum' starring Saif Ali Khan, Aftab Shivdasani and Jackie Shroff in lead roles.
00:02:49

Throwback Video: Muhurat Of Sanam O Sanam (1993)

Sanam O Sanam is a Hindi film produced by Anup Jalota and directed by Barkhaa Roy. It stars Vinod Khanna, Reena Roy, Ronit Roy,...

The United States government will pay Johnson and Johnson over $1 billion for 100 million portions of its potential coronavirus vaccine, as it loads up on antibody and medications trying to tame the pandemic.

The most recent agreement is estimated at generally $10 per immunization portion created by J&J, or $20 per portion, including a second $1 billion from the U.S. government vowed to J&J in March. That would be generally in accordance with the $19.50 per portion that the U.S. is paying for the antibody being created by Pfizer Inc and German biotech BioNTech SE.

J&J is contemplating both one and two-portion regimens of its antibody. Pfizer and BioNTech‘s competitor would require two dosages for each individual treated. The drugmaker said on Wednesday it would convey the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-revenue driven premise to be utilized after endorsement or crisis use approval by the U.S. Food and Drug Administration (FDA).

The U.S. government may likewise buy an extra 200 million dosages under a resulting understanding. J&J didn’t uncover that arrangement’s worth.

As the race for antibodies and medicines for COVID-19 increases, the U.S. government has been marking arrangements to get them through its Operation Warp Speed program. Different drugmakers who have marked arrangements incorporate Sanofi SA and Regeneron Inc.

Also Read – OYO’s Ritesh Agarwal sets up Aroa Ventures to invest in startups

This is J&J‘s first arrangement to flexibly its investigational vaccine to a nation. Talks are in progress with the European Union, however, no arrangement has yet been reached.

J&J’s investigational Vaccine is right now being tried on solid volunteers in the United States and Belgium in the beginning phase study.

There are at present no endorsed antibodies for COVID-19. More than 20 are in clinical preliminaries.

Shares of J&J were up around 1 percent in early exchanging on the New York Stock Exchange.

For latest entertainment news, bollywood news, hollywood news, celebrity gossips, latest movie reviews, entertainment news and gossips in hindi - follow Lehren on Facebook, Twitter and Youtube.

↓       Scroll down for next story      ↓

00:01:08

Amitabh Bachchan Says, “I Can’t Read, Write Or See”

Bollywood legend Amitabh Bachchan regularly gives his fans an update about his work and life in general. And in his recent update, he told...
00:01:08

Mann Ki Awaaz Pratigya 2: Pratigya Is All Set To Hit Back At...

Mann Ki Awaaz Pratigya 2 will take a leap of nine years from where the original story ended. The makers have released a strong...
00:01:07

Charu Asopa Entry To Create High Voltage Drama In Kyun Utthe Dil Chhod...

Whenever there is a new entry in a show the story automatically takes new twists and turns. This is what is going happened with...
- Advertisement -